Ionis Pharmaceuticals (IONS) Return on Sales (2009 - 2026)

Ionis Pharmaceuticals' Return on Sales history runs 18 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Sales rose 1.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q1 2026 at Ionis Pharmaceuticals, up from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.62% in Q2 2025 to a low of 0.01% in Q1 2024.
• Historically, Return on Sales has averaged 0.03% across 5 years, with a median of 0.0% in 2024.
• The sharpest annual moves came in 2022 and 2025: Return on Sales slipped 1 bps in 2022, then jumped 62 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then soared by 92 bps to 0.0% in 2023, then slumped by 1524 bps to 0.0% in 2024, then slumped by 145 bps to 0.01% in 2025, then surged by 67 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.